Press Releases

Investor E-mail Alert Service: You can automatically receive Press Release alerts via e-mail by subscribing now.

Keyword Search
 
11/16/2017
BD to Introduce Integrated Medication Management Platform Designed to Address Hospitals' Greatest Challenges at #ASHP17
11/16/2017
BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines
11/02/2017
BD Announces Results For 2017 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2018 Guidance
10/26/2017
BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
10/25/2017
BD Breaks Ground on $60 Million Expansion of Nebraska Manufacturing Facility
10/18/2017
BD Statement On European Commission Conditional Clearance Of Bard Acquisition
10/05/2017
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
09/29/2017
Timothy M. Ring and David F. Melcher to Join BD Board of Directors
09/27/2017
BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
09/26/2017
BD Expands Efforts to Combat Antimicrobial Resistance with New Diagnostic Test in Europe
09/20/2017
BD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sexually-Transmitted Pathogens
09/19/2017
BD Introduces New 6mm Pen Needle for Injection Pens
09/12/2017
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
09/08/2017
BD to Present at the Morgan Stanley Global Healthcare Conference 2017
08/29/2017
BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
08/08/2017
Bard Shareholders Approve Proposed Merger With Becton, Dickinson
08/03/2017
BD Announces Results For 2017 Third Fiscal Quarter
08/01/2017
BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
07/25/2017
BD Board Declares Dividend
07/19/2017
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
07/18/2017
BD Transforms Microbiology Urine Testing
07/06/2017
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
07/03/2017
BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
06/20/2017
BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
06/09/2017
BD and Bard Receive Second Requests from FTC under HSR Act
06/05/2017
BD Receives FDA 510(K) Clearance for Molecular Test for Harmful Intestinal Bacteria Causing Infectious Diarrhea
06/05/2017
BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
05/23/2017
BD Board Declares Dividend
05/19/2017
BD Announces Results of Early Tenders and Amendments to Exchange Offers
05/15/2017
BD to Present at Investor Healthcare Conferences
05/12/2017
BD Announces Exercise of Option to Purchase Additional Shares by Underwriters of Public Equity Offerings Increasing Total Gross Proceeds to $4.95 Billion
05/10/2017
BD Prices Offerings of $2.25 Billion of Common Stock and $2.25 Billion of Depositary Shares Representing Interests in Mandatory Convertible Preferred Stock
05/09/2017
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
05/07/2017
BD Announces Offerings of $2.25 Billion of Common Stock and $2.25 Billion of Depositary Shares Representing Interests in Mandatory Convertible Preferred Stock
05/05/2017
BD Announces Commencement of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
05/02/2017
BD Announces Results For 2017 Second Fiscal Quarter
04/27/2017
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
04/26/2017
BD Licenses Novel Molecular Indexing Technology to Roche
04/23/2017
BD Announces Appointment Of Tom Polen As President
04/23/2017
BD To Acquire Bard For $24 Billion
04/06/2017
BD Receives FDA 510(k) Clearance for New Flow Cytometer System with Leucocount Reagent Assay
04/04/2017
BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
04/04/2017
BD Completes Acquisition Of Caesarea Medical Electronics
04/03/2017
BD Launches "Power in Prevention" Program to Help Minimize Risk of Infections during Surgical Process at 2017 AORN Annual Conference
02/22/2017
BD To Present At Inaugural CECP CEO Investor Forum
02/22/2017
BD Veritor™ System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
02/21/2017
BD Partnership Honored by U.S. Chamber of Commerce Foundation at the Health Means Business National Summit with Healthy10 Award
02/20/2017
BD Demonstrates Synchronized Technology Platform at HIMSS17
02/17/2017
BD to Present at Investor Healthcare Conferences
02/16/2017
BD Initiates New Industry Alliance To Combat Rising Opioid Crisis
02/13/2017
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
02/02/2017
BD Announces Results For 2017 First Fiscal Quarter
01/26/2017
New BD Institute For Medication Management Excellence Aims To Improve Patient Safety And Outcomes Through Collaboration
01/23/2017
BD Board Declares Dividend
01/23/2017
PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
01/18/2017
BD Announces Webcast of Annual Meeting of Shareholders
01/17/2017
BD Launches Reagents to Simplify Single Cell Research
01/11/2017
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
01/09/2017
BD to Present at the 35th Annual J. P. Morgan Healthcare Conference